PACT Pharma

All edits

Edits on 16 Jun, 2021

"prospector:333:163480"

Erin Scherfner edited on 16 Jun, 2021

View Changes

Edits made to:

Infobox (+2 properties)

Infobox

Country

United States

Industry

Biomedical engineering

Edits on 13 May, 2021

Dushyant Soni edited on 13 May, 2021

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Facebook

https://www.facebook.com/login/?next=https%3A%2F%2Fwww.facebook.com%2Fpages%2Fcategory%2FPharmaceutical-Company%2FPACT-Pharma-111723870609974%2F

Edits on 12 May, 2021

"Funding autocalculation"

Golden AI edited on 12 May, 2021

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Latest funding type

‌

Series C round

Edits on 1 May, 2021

"Infobox creation from: 2 Corporate Dr South San Francisco, CA, 94080-7047 United States"

Golden AI edited on 1 May, 2021

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Location

South San Francisco, California

Bhupendra Solanki edited on 1 May, 2021

View Changes

Edits made to:

Infobox (+2 properties)

Infobox

Full address

2 Corporate Dr South San Francisco, CA, 94080-7047 United States

Twitter

https://twitter.com/pactpharma?lang=en

Edits on 29 Mar, 2021

"Found on funding round"

Golden AI edited on 29 Mar, 2021

View Changes

Edits made to:

Infobox (+6 properties)

Infobox

Investors

Wei Guo (entrepreneur)

Edits on 20 Mar, 2021

Henry Ogolla edited on 20 Mar, 2021

View Changes

Edits made to:

Timeline (+1 events) (+64 characters)

Timeline

March 5, 2021

PACT Pharma announces planned retirement of CEO Alex Franzusoff.

Edits on 3 Mar, 2021

"Funding autocalculation"

Golden AI edited on 3 Mar, 2021

View Changes

Edits made to:

Infobox (+2 properties)

Infobox

Latest funding round date

January 11, 2020

Total funding amount (USD)

200,000,000

Edits on 24 Feb, 2021

Golden AI edited on 24 Feb, 2021

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Funding rounds

‌

PACT Pharma Series C round, January 11, 2020

Golden AI edited on 24 Feb, 2021

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Funding rounds

‌

PACT Pharma Series B round, May 25, 2018

Golden AI edited on 24 Feb, 2021

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Funding rounds

‌

PACT Pharma Series A round, December 20, 2016

Edits on 18 Feb, 2021

"prospector:157:88160"

Golden AI edited on 18 Feb, 2021

View Changes

Edits made to:

Infobox (+2 properties)

Infobox

Industry

‌

Pharmaceuticals Industry

Legal classification

Corporation

Edits on 8 Feb, 2021

Joseph Burns edited on 8 Feb, 2021

View Changes

Edits made to:

Infobox (+1/--1 properties)

Infobox

B2X

‌

B2B

https://www.linkedin.com/company/pact-pharma-immuno-oncology/

Amy Tomlinson Gayle edited on 8 Feb, 2021

View Changes

Edits made to:

Infobox (--1 properties)

Infobox

Number of Employees (ranges)

100 – 249

Amy Tomlinson Gayle edited on 8 Feb, 2021

View Changes

Edits made to:

Infobox (+12/--1 properties)

Infobox

CEO

‌

Alex Franzusoff

Legal name

PACT Pharma, Inc.

Company status

Active

Founded date

2016

Founder

Industry

Pharmaceutical industry

‌

Biopharmaceutical

Legal classification

Privately Held Company (company)

Location

Hayward, California

Edits on 4 Dec, 2020

Jude Gomila approved a suggestion from Golden's AI on 4 Dec, 2020

View Changes

Edits made to:

Article (+14/-14 characters)

Article

PACT Pharma raised $95 million in Series B financing. Alphabet Inc.'s venture arm GV led the round, with participation from Invus Group, Canaan Partners, Casdin CapitalCasdin Capital, Wu Capital and other undisclosed investors.

Edits on 2 Dec, 2020

"prospector:86:49962"

Golden AI edited on 2 Dec, 2020

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Is a

Company

"prospector:86:49962"

Golden AI edited on 2 Dec, 2020

View Changes

Edits made to:

Infobox (+1 properties)

Infobox

Website

http://pactpharma.com

Edits on 17 Nov, 2018

Jude Gomila approved a suggestion from Golden's AI on 17 Nov, 2018

View Changes

Edits made to:

Article (+13/-13 characters)

Article

PACT Pharma raised $95 million in Series B financing. Alphabet Inc.Alphabet Inc.'s venture arm GV led the round, with participation from Invus Group, Canaan Partners, Casdin Capital, Wu Capital and other undisclosed investors.

Edits on 2 Oct, 2018

Carla Faraguna edited on 2 Oct, 2018

View Changes

Edits made to:

Description (-37 characters)

Article (+2/-8 characters)

Categories (+1 topics)

PACT Pharma is dedicated to synthesizing a tsunami of neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each individual cancer patient.

Article

The technology in development at PACT Pharma aims to reprogram immune systems to target and eradicate the cancer. PACT Pharma is engineering synthetic tumor-infiltrating lymphocytes (synthetic TILs), tailored for each patient's cancer with highly efficient turnaround in manufacturing from tumor biopsy to re-infusion of autologous synthetic TILs back into the patient.